# Blackrock Neurotech

Blackrock Neurotech is an other based in Salt Lake City, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Salt Lake City, United States
- **Region:** North America
- **Address:** 630 Komas Drive, Suite 200, Salt Lake City, UT 84108, United States
- **Assets under management:** Undisclosed
- **Website:** blackrockneurotech.com
- **LinkedIn:** https://www.linkedin.com/company/blackrock-neurotech

## Regulatory record

- **Reports private funds:** No

## About

Implantable brain technology changing lives. | Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders.

## Sectors

- Neuroscience
- MedTech
- AI/ML
- Deep Tech

## People

- Marcus Gerhardt — Co-Founder & CEO
- Florian Solzbacher — Co-Founder & CSO
- Christian Angermayer — Co-Chairman
- Tim Sievers — Co-Chairman
- Thomas Thiele — CFO

## Questions

### Who runs investment decisions at Blackrock Neurotech?

Marcus Gerhardt serves as CEO. The board is co-chaired by Christian Angermayer, founder of Apeiron Investment Group, and Tim Sievers, founder of Deposit Solutions. Strategic direction involves both executive leadership and academic co-founder Florian Solzbacher (per the firm's website).

### How does Blackrock Neurotech source its technology and IP?

The core technology originates from research at the University of Utah, where co-founder Florian Solzbacher holds a chaired professorship. The firm has licensed or transferred university-developed patents into a commercial platform, typical of university spinouts in the neurotechnology space.

### What investment stages does Blackrock Neurotech typically target?

The firm does not invest in external companies — it is an operating company that develops and commercializes its own neurotechnology products. Its stage focus is on clinical and commercial deployment rather than external portfolio building.

## Related profiles

- [Tenor Capital Management](https://altss.com/profile/tenor-capital-management)
- [Xanitos Inc.](https://altss.com/profile/xanitos-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/blackrock-neurotech

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology